脂质聚合物混合纳米系统:一种合理的融合,用于先进的治疗交付
Shweta Jain1, Mudit Kumar2, Pushpendra Kumar2
1Sir Madan Lal Institute of Pharmacy, Etawah 206310, India.
Journal of functional biomaterials
|September 27, 2023
概括
脂质聚合物混合纳米粒子 (LPHNPs) 提供了比传统的脂质纳米粒子 (LNPs) 更好的药物输送. 本综述侧重于核心外的LPHNP,详细介绍其制备,特性和临床潜力.
科学领域:
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 脂质纳米颗粒 (LNP) 在向药物输送,循环时间和稳定性方面面临限制.
- 脂质聚合物混合纳米粒子 (LPHNPs) 结合了脂质体和聚合物纳米粒子的优势.
- 具有聚合物核心和脂质外的核心外LPHNP特别有希望.
研究的目的:
- 审查LPHNP的组成,制备方法和分类.
- 要突出表面功能化,释放机制和LPHNP的特性.
- 强调核心外LPHNP在药物输送中的临床相关性和潜力.
主要方法:
- 对LPHNP制备技术 (例如,ESE,纳米沉) 的现有文献的审查.
- 分析不同的LPHNP结构 (单立体,核心外,中空核心外,仿生,聚合物).
- 专注于核心外LPHNP的表征和应用.
主要成果:
- 与传统的LNP相比,LPHNP提供了增强的药物输送.
- 核心的LPHNP显示出治疗各种疾病的巨大潜力.
- 有各种各样的制备方法和结构,其中核心外是最常见的.
结论:
- LPHNP代表了药物输送的先进平台,克服了LNP的局限性.
- 核心的LPHNP是由于其生物相容性和多功能性而成为一个关键焦点.
- 需要进一步的研究和临床试验来探索LPHNP的治疗应用.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


